Skip to content

Med-stat.info

The latest health news

  • Coronavirus
  • Biotech
  • Health Tech
  • First Opinion
  • In the Lab
  • Pharma
Main Menu

Tag: biosimilars Congress

First Opinion

Opinion: The hurried push by Congress to address drug costs shouldn’t undermine the vast savings from generics and biosimilars

06.11.2021

Americans rightfully expect Congress to address the ever-increasing prices of brand-name prescription drugs. But the wholesale policy changes now under rushed consideration in Congress will undermine the only proven solution …

Read More
Copyright © Med-stat.info
  • Terms of Service
  • Privacy Policy